Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Drug Resistance, Multiple/drug effects"'
Autor:
Melisa Edith Gantner, Roxana Noemi Peroni, Juan Francisco Morales, Alan Talevi, Maria Villalba, María Esperanza Ruiz
Publikováno v:
SEDICI (UNLP)
Universidad Nacional de La Plata
instacron:UNLP
Universidad Nacional de La Plata
instacron:UNLP
Breast Cancer Resistance Protein (BCRP) is an ATP-dependent efflux transporter linked to the multidrug resistance phenomenon in many diseases such as epilepsy and cancer and a potential source of drug interactions. For these reasons, the early identi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cfce6427c4384d52c3f06e60a0245fa1
https://doi.org/10.1021/acs.jcim.7b00016
https://doi.org/10.1021/acs.jcim.7b00016
Autor:
François-Xavier Weill
Publikováno v:
médecine/sciences
médecine/sciences, EDP Sciences, 2010, 26 (11), pp.969-75. ⟨10.1051/medsci/20102611969⟩
médecine/sciences, 2010, 26 (11), pp.969-75. ⟨10.1051/medsci/20102611969⟩
médecine/sciences, EDP Sciences, 2010, 26 (11), pp.969-75. ⟨10.1051/medsci/20102611969⟩
médecine/sciences, 2010, 26 (11), pp.969-75. ⟨10.1051/medsci/20102611969⟩
International audience; The introduction of chloramphenicol in 1948 revolutionised the outcome of typhoid fever but chloramphenicol-resistant strains of Salmonella enterica serotype Typhi were reported just two years later. Resistance followed also t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc0ae9c8acb8505ab17b76ca331c1bc6
https://doi.org/10.1051/medsci/20102611969
https://doi.org/10.1051/medsci/20102611969
Autor:
David S. Perlin, Yanan Zhao, Dimitrios Farmakiotis, Shawn R. Lockhart, Dimitrios P. Kontoyiannis, Jack D. Sobel, Barbara D. Alexander, Winder B. Perez, Dominique Sanglard, Erika Shor, Saad J. Taj-Aldeen, Cristina Jiménez-Ortigosa, Kelley R. Healey
Publikováno v:
Nature Communications, vol. 7, pp. 11128
Nature Communications, Vol 7, Iss 1, Pp 1-10 (2016)
Nature Communications
Nature Communications, Vol 7, Iss 1, Pp 1-10 (2016)
Nature Communications
The fungal pathogen Candida glabrata has emerged as a major health threat since it readily acquires resistance to multiple drug classes, including triazoles and/or echinocandins. Thus far, cellular mechanisms promoting the emergence of resistance to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a40860f10193fc2a5f4ddda277a82fd
https://serval.unil.ch/notice/serval:BIB_55BE139CDF92
https://serval.unil.ch/notice/serval:BIB_55BE139CDF92
Autor:
Soo Chan Lee, Anne-Claude Gingras, Joseph Heitman, Paola Coccetti, Corey Nislow, Karolina Niewola-Staszkowska, Ron Ammar, Katja Döhl, A. A. Leslie Gunatilaka, Anna F. Averette, Taeyup Kim, David R. Andes, Yong Sun Bahn, Lutz Schmitt, E. M. Kithsiri Wijeratne, G. M. Kamal B. Gunaherath, Frederick P. Roth, Dominique Sanglard, Leah E. Cowen, Robbie Loewith, Farida Tripodi, Tanvi Shekhar-Guturja, Jean-Philippe Lambert
Publikováno v:
Nature chemical biology
Nature chemical biology, vol. 12, no. 10, pp. 867-875
Nature chemical biology, Vol. 12, No 10 (2016) pp. 867-875
Nature chemical biology, vol. 12, no. 10, pp. 867-875
Nature chemical biology, Vol. 12, No 10 (2016) pp. 867-875
There is an urgent need for new strategies to treat invasive fungal infections, which are a leading cause of human mortality. Here, we establish two activities of the natural product beauvericin, which potentiates the activity of the most widely depl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df123ffb668df12b0d34f328ccb34f16
https://pubmed.ncbi.nlm.nih.gov/27571477
https://pubmed.ncbi.nlm.nih.gov/27571477
Autor:
Herbert D. Spapen, Viola Van Gorp, Jouke De Regt, Patrick M. Honore, Rita Jacobs, Elisabeth De Waele
Publikováno v:
Critical Care
We read with great interest the article by Rocco and colleagues [1] that retrospectively evaluated risk factors for acute kidney injury in critically ill patients receiving colistin and the subsequent comments by Rachid and colleagues [2]. Although o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c95123ca7e98fa18c283fa03347d3d58
https://doi.org/10.1186/cc13747
https://doi.org/10.1186/cc13747
Autor:
Vinšová, Jarmila, Krátký, Martin
The emergence of resistance to anti-tuberculosis drugs, particularly of MDR-TB and newly XDR-TB, has become a major public health problem. The current treatment regiment has several disadvantages, i.e. long treatment period (DOTS takes minimum 6 mont